110385 ⎘
Reverse transcribing RNA viruses; Details; Retroviridae; Lentivirus, not HIV, e.g. FIV, SIV; Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
ENGINEERED ENVELOPED VECTORS AND METHODS OF USE THEREOF
#2METHODS AND COMPOSITIONS FOR SYNTHETIC EVOLUTION
#3COMPOSITIONS AND METHODS FOR PURIFYING LENTIVIRUS PARTICLES
#4Retroviral and Lentiviral Vectors
#5GLYCOPROTEINS FOR PSEUDOTYPING RETROVIRAL VECTOR PARTICLES
#6VIRUS VECTOR PRODUCTION
#7VIRAL VECTOR PRODUCTION
#8HIGH CAPACITY LENTIVIRAL VECTORS
#9SYSTEMS AND METHODS FOR VIRAL TRANSFECTION OF CELLS IN A BIOREACTOR
#10METHODS IN LENTIVIRAL MANUFACTURING FOR PRODUCTION OF CAR-T CELL DRUG PRODUCTS
#11SERUM-FREE SUSPENSION SYSTEM FOR LENTIVIRAL PRODUCTION
#12VIRAL VECTORS AND PACKAGING CELL LINES
#13VIRAL VECTORS AND PACKAGING CELL LINES
#14LENTIVIRAL VECTOR
#15HIV PRE-IMMUNIZATION AND IMMUNOTHERAPY
#16THREE-DIMENSIONAL BIOREACTOR INCLUDING FILLED VOID STRUCTURE
#17LENTIVIRAL VECTOR, LENTIVIRAL PARTICLE FOR TREATING HEPATITIS B AND ITS PREPARATION METHOD AND APPLICATION THEREOF
#18ENGINEERED PNMA PROTEINS AND DELIVERY SYSTEMS THEREOF
#19METHODS AND SYSTEMS OF PARTICLE PRODUCTION
#20CELL-TYPE SPECIFIC MEMBRANE FUSION PROTEINS
#21MODIFIED PARAMYXOVIRIDAE ATTACHMENT GLYCOPROTEINS
#22KOALA RETROVIRUS ENVELOPE GYLCOPROTEINS AND USES THEREOF
#23VIRAL VECTOR PRODUCTION SYSTEM
#24GENOMIC RNA PACKAGING ENHANCER ELEMENT
#25METHODS FOR SCREENING GENETIC PERTURBATIONS
#26RETARGETED RETROVIRAL VECTORS AND COMPOSITIONS OR METHODS OF USE THEREOF
#27NUCLEIC ACID CONSTRUCT FOR AIDS GENE THERAPY
#28VECTOR MANUFACTURING PROCESSES
#29VIRAL VECTOR PRODUCTION SYSTEMS, ENGINEERED CELLS FOR VIRAL VECTOR PRODUCTION, AND METHODS OF USE THEREOF
#30HIV PRE-IMMUNIZATION AND IMMUNOTHERAPY
#31Targeted Destruction of Viral RNA by CRISPR-Cas13
#32PACKAGING CELLS WITH TARGETED GENE KNOCKOUTS THAT IMPROVE RETROVIRAL VECTOR TITERS
#33Factor VIII Molecules and Their Use
#34Method for promoting the stemness and/or transdifferentiation of acinar cells
#35LENTIVIRUS PROTECTION VIA Fc OVEREXPRESSION
#36STABLE LENTIVIRUS PACKAGING CELL LINE AND PREPARATION METHOD THEREFOR
#37SPIKE-IN REFERENCE STANDARD FOR USE IN DETECTING SAMPLE TARGET FROM DNA OR RNA ORGANISM
#38PRE-IMMUNIZATION AND IMMUNOTHERAPY
#39HEK293T CELL STRAIN HAVING HIGH DISPERSIBILITY AND SCREENING METHOD THEREFOR
#40Retroviral And Lentiviral Vectors
#41METHODS FOR PREPARATION OF SHELF-STABLE PLASMID DNA/POLYCATION PARTICLES WITH DEFINED SIZES FOR CELL TRANSFECTION
#42VIRAL VECTORS AND USES THEREOF
#43ENGINEERED ENVELOPED VECTORS AND METHODS OF USE THEREOF
#44Production of Lentiviral Vectors
#45VIRAL VECTOR PRODUCTION
#46LENTIVIRUS PACKAGING VECTOR AND PACKAGING METHOD THEREFOF
#47CO-PACKAGING TO MITIGATE INTERMOLECULAR RECOMBINATION
#48ENGINEERED CYCLIC PEPTIDES FOR ENHANCING VIRAL PRODUCTION
#49LENTIVIRAL VECTORS ENABLING ROUTING ANTIGENS TO MHC-II PATHWAY AND INDUCING CD4+ AND CD8+ T-CELL RESPONSES IN A HOST
#50IMPROVED GENERATION OF LENTIVIRAL VECTORS FOR T CELL TRANSDUCTION USING COCAL ENVELOPE
#51COMPOSITIONS AND METHODS FOR TARGETING TUMOR ASSOCIATED TRANSCRIPTION FACTORS
#52LENTIVIRAL VECTOR MANUFACTURING PROCESS IN PACKED BED BIOREACTOR
#53Lentiviral System
#54Cells expressing recombinant growth factor receptors
#55Retroviral vector
#56Digital-to-analog conversion apparatus and method having signal calibration mechanism
#57DEPLETION OF EXT1 EXPRESSION AND/OR ACTIVITY IMPROVES CELLULAR PRODUCTION OF BIOLOGICAL ENTITIES
#58Lentiviral Vectors
#59CRISPR-Cas13 crRNA Arrays
#60PRODUCTION CELL AND PACKAGING CELL FOR RETROVIRAL VECTOR AND PREPARATION METHOD THEREFOR
#61Novel Vectors and Uses Thereof
#62CHIMERIC ANTIGEN RECEPTOR TARGETING CLL1 AND USE THEREOF
#63SERUM-FREE SUSPENSION SYSTEM FOR LENTIVIRAL PRODUCTION
#64Enhancing Production of Lentiviral Vectors
#65CD25 PRE-SELECTIVE COMBINATION ANTI-HIV VECTORS, TARGETING VECTORS, AND METHODS OF USE
#66METHODS AND COMPOSITIONS FOR THE MODIFICATION AND DELIVERY OF LYMPHOCYTES
#67CD24-ASSOCIATED PARTICLES AND RELATED METHODS AND USES THEREOF
#68CYBB LENTIVIRAL VECTOR, LENTIVIRAL VECTOR-TRANSDUCED STEM CELL, AND PREPARATION METHOD AND APPLICATION THEREOF
#69Lentivirus packaging system comprising a synthetic positive feedback loop
#70METHOD FOR INCREASING LENTIVIRAL VECTOR PRODUCTION
#71Retroviral and lentiviral vectors
#72HIV pre-immunization and immunotherapy
#73LDLR negative packaging cell line for the production of VSV-G pseudotyped retroviral vector particles or virus particles thereof
#74VIRUS VECTOR PRODUCTION
#75Lentiviral vector and method for delivering exogenous RNA by the lentiviral vector
#76Viral vectors and packaging cell lines
#77Methods for screening genetic perturbations
#78VIRAL AND NON-VIRAL NANOPLASMID VECTORS WITH IMPROVED PRODUCTION
#79Expression vectors comprising engineered genes
#80Viral vector production
#81CD25 PRE-SELECTIVE COMBINATION ANTI-HIV VECTORS, TARGETING VECTORS, AND METHODS OF USE
#82HIV pre-immunization and immunotherapy
#83Viral vector production system
#84Stable cell lines for retroviral production
#85PACS1 ENHANCEMENT FOR REV-DEPENDENT LENTIVIRAL VECTORS
#86HIV pre-immunization and immunotherapy
#87Genomic RNA packaging enhancer element
#88HIV pre-immunization and immunotherapy
#89Method and kit for viral vector isolation
#90Retroviral and lentiviral vectors
#91Lentivirus packaging system comprising a synthetic positive feedback loop
#92Multigenome retroviral vector preparations and methods and systems for producing and using same
#93Large commercial scale lentiviral vector production system and vectors produced thereby
#94HIV pre-immunization and immunotherapy
#95Serum-free suspension system for lentiviral production
#96Cell Lines
#97Retroviral and lentiviral vectors
#98HIV pre-immunization and immunotherapy
#99Methods and compositions for transducing lymphocytes and regulated expansion thereof
#100Multigenome retroviral vector preparations and methods and systems for producing and using same
#101CONDITIONAL CYTOTOXIC GENE THERAPY VECTOR FOR SELECTABLE STEM CELL MODIFICATION FOR ANTI HIV GENE THERAPY
#102Pseudotyped lentiviral vectors
#103Viral vector production system
#104Method for producing enveloped viruses
#105Genomic RNA packaging enhancer element
#106LARGE COMMERCIAL SCALE LENTIVIRAL VECTOR PRODUCTION SYSTEM AND VECTORS PRODUCED THEREBY
#107High yield suspension cell line, system and method for making same
#108Modified cell lines for increasing lentiviral titers
#109Baculoviruses with enhanced virion production and a method for the production of baculoviruses
#110Modified Cell Lines for Increasing Lentiviral Titers
#111Methods for enhancing infectivity of retroviruses
#112EXPRESSION OF NEUROPEPTIDES IN MAMMALIAN CELLS
#113CCR7 ligand delivery and co-delivery in immunotherapy
#114Bovine immunodeficiency virus (BIV) based vectors
#115Method
#116Retroviral vectors
#117Bovine immunodeficiency virus (BIV) based vectors
#118Vectors
#119Method
#120Lentiviral packaging constructs
#121Gene Therapy of Solid Tumours by Means of Retroviral Vectors Pseudotyped With Arenavirus Glycoproteins
#122Lentiviral packaging constructs
#123Bovine immunodeficiency virus (BIV) based vectors
#124Chimaeric vector system
#125Retroviral vectors
#126Heterologous retroviral packaging system
#127Lentiviral packaging constructs
#128Retroviral vectors
#129Bovine immunodeficiency virus (BIV) based vectors
#130Vector packaging cell line
#131Bovine immunodeficiency virus (BIV) based vectors
#132Recombinant bovine immunodeficiency virus based gene transfer system
#133Bovine immunodeficiency virus (BIV) based vectors
#134Bovine immunodeficiency virus (BIV) based vectors
#135Secretion of neublastin
#136Method